Further increase in startup liquidations
Swiss startup liquidations rose for a third consecutive year to 158 in 2025 amid a post‑2022 funding squeeze. Biotech liquidations jumped 250% to 14, later‑stage failures increased and the average age of closed startups reached 8.3 years, driven by a cohort of weakly funded 2019–2021 companies losing follow‑on capital.
Why it mattersBiotech liquidations rose to 14 in 2025, so investors must tighten follow-on funding standards.